- Home
- CDTX vs SHOO Comparison
CDTX vs SHOO Comparison
Compare CDTX & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- SHOO
- Stock Information
- Founded
- CDTX 2012
- SHOO 1990
- Country
- CDTX United States
- SHOO United States
- Employees
- CDTX N/A
- SHOO N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- SHOO Shoe Manufacturing
- Sector
- CDTX Health Care
- SHOO Consumer Discretionary
- Exchange
- CDTX Nasdaq
- SHOO Nasdaq
- Market Cap
- CDTX 2.8B
- SHOO 2.5B
- IPO Year
- CDTX 2015
- SHOO 1993
- Fundamental
- Price
- CDTX $219.75
- SHOO $37.77
- Analyst Decision
- CDTX Buy
- SHOO Buy
- Analyst Count
- CDTX 13
- SHOO 8
- Target Price
- CDTX $119.44
- SHOO $40.00
- AVG Volume (30 Days)
- CDTX 2.2M
- SHOO 1.3M
- Earning Date
- CDTX 11-06-2025
- SHOO 11-05-2025
- Dividend Yield
- CDTX N/A
- SHOO 2.22%
- EPS Growth
- CDTX N/A
- SHOO N/A
- EPS
- CDTX N/A
- SHOO 0.78
- Revenue
- CDTX N/A
- SHOO $2,362,727,000.00
- Revenue This Year
- CDTX N/A
- SHOO $11.74
- Revenue Next Year
- CDTX N/A
- SHOO $10.47
- P/E Ratio
- CDTX N/A
- SHOO $48.56
- Revenue Growth
- CDTX N/A
- SHOO 6.41
- 52 Week Low
- CDTX $15.02
- SHOO $19.05
- 52 Week High
- CDTX $220.32
- SHOO $46.76
- Technical
- Relative Strength Index (RSI)
- CDTX 89.35
- SHOO 59.53
- Support Level
- CDTX $102.46
- SHOO $36.20
- Resistance Level
- CDTX $218.85
- SHOO $39.86
- Average True Range (ATR)
- CDTX 4.30
- SHOO 1.54
- MACD
- CDTX 12.80
- SHOO -0.08
- Stochastic Oscillator
- CDTX 99.47
- SHOO 71.81
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.